Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Rectal Obstruction, CTCAE"
Page 1
Timing of High-Dose-Rate Brachytherapy With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Localized Prostate Cancer and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial (THEPCA).
Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):90-99. doi: 10.1016/j.ijrobp.2023.11.011. Epub 2023 Dec 30.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 38163520
Clinical Trial.
Suppression of prostate-specific antigen (PSA) and signals for survival differences were also analyzed. METHODS AND MATERIALS: This was a single-center randomized trial in patients with intermediate- and high-risk localized prostate cancer who received HDR-BT before …
Suppression of prostate-specific antigen (PSA) and signals for survival differences were also analyzed. METHODS AND MATERIALS: This was a si …
A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients.
Petersen SE, Thorsen LB, Hansen S, Petersen PM, Lindberg H, Moe M, Petersen JB, Muren LP, Høyer M, Bentzen L.
Petersen SE, et al.
Acta Oncol. 2022 Feb;61(2):179-184. doi: 10.1080/0284186X.2021.1979246. Epub 2021 Sep 20.
Acta Oncol. 2022.
PMID: 34543143
Clinical Trial.
RESULTS: Median follow-up (FU) time was 4.6 years. No persistent late CTCAE grade 3+ morbidity was observed. Prevalence of CTCAE grade 2+ GI morbidities varied from 0 to 6% at baseline throughout FU time, except for diarrhea, which was reported …
RESULTS: Median follow-up (FU) time was 4.6 years. No persistent late CTCAE grade 3+ morbidity was observed. Prevalence of …
Item in Clipboard
Cite
Cite